chrX-120159230-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_032498.3(RHOXF2):c.295G>A(p.Gly99Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,206,188 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032498.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHOXF2 | NM_032498.3 | c.295G>A | p.Gly99Ser | missense_variant | 2/4 | ENST00000371388.5 | NP_115887.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOXF2 | ENST00000371388.5 | c.295G>A | p.Gly99Ser | missense_variant | 2/4 | 1 | NM_032498.3 | ENSP00000360441.3 |
Frequencies
GnomAD3 genomes AF: 0.0000720 AC: 8AN: 111183Hom.: 0 Cov.: 19 AF XY: 0.0000297 AC XY: 1AN XY: 33627
GnomAD3 exomes AF: 0.0000445 AC: 8AN: 179898Hom.: 0 AF XY: 0.0000454 AC XY: 3AN XY: 66008
GnomAD4 exome AF: 0.0000137 AC: 15AN: 1094962Hom.: 0 Cov.: 31 AF XY: 0.00000832 AC XY: 3AN XY: 360570
GnomAD4 genome AF: 0.0000719 AC: 8AN: 111226Hom.: 0 Cov.: 19 AF XY: 0.0000297 AC XY: 1AN XY: 33680
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2022 | The c.295G>A (p.G99S) alteration is located in exon 2 (coding exon 2) of the RHOXF2 gene. This alteration results from a G to A substitution at nucleotide position 295, causing the glycine (G) at amino acid position 99 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | RHOXF2: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at